| 证券代码 | PAVMW.O |
| 证券名称 | PAVmed Inc Wt |
| 证券类型 | 美国权证 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2016-07-27 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | - |
| 公司名称 | PAVmed Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | One Grand Central Place, Suite 4600, New York, USA |
| 成立日期 | 2014-06-26 |
| 董事会主席 | - |
| 公司属地 | United States 美国 |
| 公司网址 | www.pavmed.com |
| 电话 | +1 (212) 949-4319 |
| 传真 | - |
| 公司简介 | PAVmed Inc. operates as a medical device company in the United States. The company’s product pipeline includes NextFlo, a disposable infusion pump; PortIO, a long-term implantable vascular access device; Caldus, a disposable tissue ablation device; CarpX, a percutaneous device to treat carpal tunnel syndrome; and NextCath, a self-anchoring short-term catheter. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is headquartered in New York, New York. |